HRP20040871A2 - Substituted amino isoxazoline derivatives and their use as anti-depressants - Google Patents

Substituted amino isoxazoline derivatives and their use as anti-depressants

Info

Publication number: HRP20040871A2
Authority: HR; Croatia
Prior art keywords: alkyl; group; radical; mono; formula
Prior art date: 2002-04-02

Application number

HR20040871A

Other languages

English (en)

Croatian (hr)

Inventor

Jose

Manuel

Margaretha

Ana

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-02

Filing date

2003-03-27

Publication date

2005-04-30

2003-03-27 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

2005-04-30 Publication of HRP20040871A2 publication Critical patent/HRP20040871A2/hr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

HR20040871A 2002-04-02 2003-03-27 Substituted amino isoxazoline derivatives and their use as anti-depressants HRP20040871A2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP02076239		2002-04-02
PCT/EP2003/003245 WO2003082878A1 (en)	2002-04-02	2003-03-27	Substituted amino isoxazoline derivatives and their use as anti-depressants.

Publications (1)

Publication Number	Publication Date
HRP20040871A2 true HRP20040871A2 (en)	2005-04-30

Family

ID=28459528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20040871A HRP20040871A2 (en)	2002-04-02	2003-03-27	Substituted amino isoxazoline derivatives and their use as anti-depressants

Country Status (24)

Country	Link
US (1)	US7265103B2 (de)
EP (1)	EP1492796B1 (de)
JP (1)	JP4580653B2 (de)
KR (1)	KR20040093061A (de)
CN (1)	CN100349897C (de)
AR (1)	AR039207A1 (de)
AT (1)	ATE372342T1 (de)
BR (1)	BR0308309A (de)
CA (1)	CA2480113C (de)
DE (1)	DE60316134T2 (de)
DK (1)	DK1492796T3 (de)
EA (1)	EA008189B1 (de)
ES (1)	ES2292949T3 (de)
HK (1)	HK1080072A1 (de)
HR (1)	HRP20040871A2 (de)
IL (2)	IL164341A0 (de)
MX (1)	MXPA04008626A (de)
NO (1)	NO20044645L (de)
NZ (1)	NZ536109A (de)
PL (1)	PL211708B1 (de)
PT (1)	PT1492796E (de)
TW (1)	TWI286138B (de)
WO (1)	WO2003082878A1 (de)
ZA (1)	ZA200407904B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR040967A1 (es) *	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
US7462717B2 (en) *	2002-08-21	2008-12-09	Janssen Pharmaceutica N.V.	C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants
US7635696B2 (en)	2004-11-26	2009-12-22	Janssen Pharmaceutica N.V.	Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
KR101150628B1 (ko) *	2007-07-03	2012-05-31	에프. 호프만-라 로슈 아게	4-이미다졸린 및 항우울제로서 이의 용도
WO2010104194A1 (en)	2009-03-10	2010-09-16	Takeda Pharmaceutical Company Limited	Benzofuran derivatives
US20130062732A1 (en)	2011-09-08	2013-03-14	International Business Machines Corporation	Interconnect structures with functional components and methods for fabrication
CN105801510A (zh) *	2016-04-08	2016-07-27	李勇	一种治疗抑郁症的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE68906340T2 (de)	1988-09-19	1993-08-12	Akzo Nv	Tetrahydronaphthalin und indan-derivate.
HUP9903706A3 (en)	1996-01-05	2000-09-28	Hoechst Marion Roussel Inc Cin	4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity, process for their preparation and pharmaceutical compositions containing the same
US6187774B1 (en) *	1996-03-04	2001-02-13	Yoshitomi Pharmaceutical Industries, Ltd.	Fused heterocyclic compounds and pharmaceutical applications thereof
ATE337322T1 (de) *	2001-02-21	2006-09-15	Janssen Pharmaceutica Nv	Isoxazolin-derivate als antidepressiva
AR040967A1 (es) *	2002-08-12	2005-04-27	Janssen Pharmaceutica Nv	Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
US7462717B2 (en) *	2002-08-21	2008-12-09	Janssen Pharmaceutica N.V.	C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressants

2003
- 2003-03-27 DE DE60316134T patent/DE60316134T2/de not_active Expired - Lifetime
- 2003-03-27 JP JP2003580343A patent/JP4580653B2/ja not_active Expired - Fee Related
- 2003-03-27 KR KR10-2004-7012757A patent/KR20040093061A/ko not_active Ceased
- 2003-03-27 BR BR0308309-8A patent/BR0308309A/pt not_active IP Right Cessation
- 2003-03-27 HR HR20040871A patent/HRP20040871A2/hr not_active Application Discontinuation
- 2003-03-27 PL PL371630A patent/PL211708B1/pl unknown
- 2003-03-27 US US10/510,220 patent/US7265103B2/en not_active Expired - Lifetime
- 2003-03-27 CN CNB038074192A patent/CN100349897C/zh not_active Expired - Fee Related
- 2003-03-27 MX MXPA04008626A patent/MXPA04008626A/es active IP Right Grant
- 2003-03-27 HK HK05112213.1A patent/HK1080072A1/zh unknown
- 2003-03-27 AT AT03714897T patent/ATE372342T1/de not_active IP Right Cessation
- 2003-03-27 DK DK03714897T patent/DK1492796T3/da active
- 2003-03-27 EA EA200401297A patent/EA008189B1/ru not_active IP Right Cessation
- 2003-03-27 NZ NZ536109A patent/NZ536109A/en unknown
- 2003-03-27 WO PCT/EP2003/003245 patent/WO2003082878A1/en not_active Ceased
- 2003-03-27 EP EP03714897A patent/EP1492796B1/de not_active Expired - Lifetime
- 2003-03-27 CA CA2480113A patent/CA2480113C/en not_active Expired - Fee Related
- 2003-03-27 IL IL16434103A patent/IL164341A0/xx unknown
- 2003-03-27 ES ES03714897T patent/ES2292949T3/es not_active Expired - Lifetime
- 2003-03-27 PT PT03714897T patent/PT1492796E/pt unknown
- 2003-04-01 TW TW092107328A patent/TWI286138B/zh not_active IP Right Cessation
- 2003-04-01 AR ARP030101126A patent/AR039207A1/es unknown
2004
- 2004-09-28 IL IL164341A patent/IL164341A/en not_active IP Right Cessation
- 2004-09-30 ZA ZA200407904A patent/ZA200407904B/xx unknown
- 2004-10-27 NO NO20044645A patent/NO20044645L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
TWI286138B (en)	2007-09-01
IL164341A0 (en)	2005-12-18
HK1080072A1 (zh)	2006-04-21
EA008189B1 (ru)	2007-04-27
EP1492796B1 (de)	2007-09-05
ES2292949T3 (es)	2008-03-16
PL211708B1 (pl)	2012-06-29
ATE372342T1 (de)	2007-09-15
DE60316134T2 (de)	2008-05-29
MXPA04008626A (es)	2004-12-06
NO20044645L (no)	2004-10-27
CA2480113A1 (en)	2003-10-09
DK1492796T3 (da)	2007-12-03
US20050222125A1 (en)	2005-10-06
PL371630A1 (en)	2005-06-27
EP1492796A1 (de)	2005-01-05
US7265103B2 (en)	2007-09-04
NZ536109A (en)	2006-06-30
IL164341A (en)	2009-06-15
KR20040093061A (ko)	2004-11-04
JP2005522469A (ja)	2005-07-28
AR039207A1 (es)	2005-02-09
WO2003082878A1 (en)	2003-10-09
DE60316134D1 (de)	2007-10-18
JP4580653B2 (ja)	2010-11-17
ZA200407904B (en)	2005-10-20
EA200401297A1 (ru)	2005-02-24
CN1642960A (zh)	2005-07-20
BR0308309A (pt)	2004-12-28
CA2480113C (en)	2012-04-24
PT1492796E (pt)	2007-11-16
TW200406414A (en)	2004-05-01
AU2003219111A1 (en)	2003-10-13
CN100349897C (zh)	2007-11-21

Legal Events

Date	Code	Title	Description
2005-04-30	A1OB	Publication of a patent application
2005-10-12	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2007-02-17	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20070217 Year of fee payment: 5
2009-01-13	OBST	Application withdrawn

Publication	Publication Date	Title
AU2002244717B2 (en)	2007-07-19	Isoxazoline derivatives as anti-depressants
AU2002244717A1 (en)	2003-02-27	Isoxazoline derivatives as anti-depressants
CA2480113C (en)	2012-04-24	Substituted amino isoxazoline derivatives and their use as anti-depressants
CA2494557C (en)	2011-10-18	Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
CA2495058C (en)	2012-01-03	C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
JP4681295B2 (ja)	2011-05-11	Ｃ−置換三環式イソオキサゾリン誘導体及び抗−うつ薬としてのそれらの使用
AU2003219111B2 (en)	2008-11-27	Substituted amino isoxazoline derivatives and their use as anti-depressants